Overview

A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amoxicillin/Clavulanate in Pediatric Subjects With Acute Otitis Media

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The primary objective is to compare the safety and efficacy of cefdinir oral suspension, 7 mg/kg/day ql2hrs for 5 days, to amoxicillin/clavulanate oral suspension 45 mg/kg/day (based on amoxicillin component), in divided doses, q12h for 10 days, in children between 6 months and 6 years of age, with AOM.

Phase:

Phase 4

Details

Lead Sponsor:

Abbott

Treatments:

Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Cefdinir
Cephalosporins
Clavulanic Acid
Clavulanic Acids